Considerations for utilizing medullary sponge kidney allografts in pediatric patients

Ruchi G Mahajan1, Jae-Hyung Chang2, Brian Runge3

  • 1Division of Pediatric Nephrology, Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.

Abstract

Insights

Medullary sponge kidney (MSK) disease can lead to kidney stones. This case study explores the successful kidney transplant of a pediatric patient with MSK, highlighting donor considerations.

Area of Science:

  • Nephrology
  • Transplantation
  • Urology

Background:

  • Medullary sponge kidney (MSK) disease is a congenital renal abnormality associated with recurrent nephrolithiasis.
  • MSK disease affects approximately 1 in 5000 individuals in the United States, posing a significant risk for kidney stone formation.
  • Recurrent nephrolithiasis in MSK disease can lead to graft dysfunction and failure.

Observation:

  • A pediatric patient with MSK disease underwent a living donor kidney transplant.
  • Post-transplant complications included nephrolithiasis, hydronephrosis, and urinary tract infection at one month.
  • Surgical intervention for an encrusted ureteral stent resolved hydronephrosis.

Findings:

  • The pediatric recipient experienced resolution of hydronephrosis after stent removal.
  • Oral medication prophylaxis successfully prevented further nephrolithiasis episodes.
  • The patient remained free of nephrolithiasis at one-year follow-up, with the donor remaining in good health.

Implications:

  • This case demonstrates the feasibility of kidney transplantation in pediatric patients with MSK disease.
  • Careful management of post-transplant complications, such as nephrolithiasis and hydronephrosis, is crucial for graft survival.
  • Expanding the donor pool to include living donors with conditions like MSK may be necessary given organ shortages.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
128
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
134
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
133
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
625